Supplementary Figure 3 from Neoadjuvant Enzalutamide Prior to Prostatectomy

التفاصيل البيبلوغرافية
العنوان: Supplementary Figure 3 from Neoadjuvant Enzalutamide Prior to Prostatectomy
المؤلفون: Mary-Ellen Taplin, Alison Hannah, Andrew Krivoshik, Gabriel P. Haas, Adam Kibel, Rosina T. Lis, Alvin M. Matsumoto, Peter S. Nelson, Steven P. Balk, Stephen Plymate, Brett T. Marck, Philip W. Kantoff, Kenneth Wu, William Novotny, Martin Sanda, Daniel W. Lin, Kim N. Chi, Elahe A. Mostaghel, Glenn J. Bubley, Neil Fleshner, Martin E. Gleave, Anthony M. Joshua, Maria S. Tretiakova, Bruce Montgomery
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Figure S3. Change in serum androgen levels after enza or enza/dut/LHRHa. Box plots of serum androgens for each cohort at initiation of therapy (day 0) and at prostatectomy (day 180) are depicted for each treatment arm. Levels of (A) pregnenolone, (B) progesterone, (C) DHEA, (D) AED, (E) testosterone, and (F) DHT were measured by mass spectroscopy. P values were calculated using the nonparametric Mann-Whitney test. Limits of quantification were 0.005 ng/mL for AED, progesterone and testosterone, 0.001 ng/mL for DHT and pregnenolone, and 0.15 ng/mL for DHEA.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f9400220dcb5043b2fe5601e296b7e
https://doi.org/10.1158/1078-0432.22463934
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....90f9400220dcb5043b2fe5601e296b7e
قاعدة البيانات: OpenAIRE